Response to: 'Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities' by Bossuyt <i>et al</i>.

Pisetsky, David S; Spencer, Diane M; Lipsky, Peter E; Rovin, Brad H

Response to: 'Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities' by Bossuyt et al.

Pisetsky, David S; Spencer, Diane M; Lipsky, Peter E; Rovin, Brad H.

Afiliación

Pisetsky DS; Department of Medicine and Immunology, Duke University Medical Center and Medical Research Service, VA Medical Center, Durham, North Carolina, USA.
Spencer DM; Department of Medicine and Immunology, Duke University Medical Center and Medical Research Service, VA Medical Center, Durham, North Carolina, USA.
Lipsky PE; RILITE Research Institute, Charlottesville, Virginia, USA.
Rovin BH; Division of Nephrology, The Ohio State University, Columbus, Ohio, USA.

Ann Rheum Dis ; 78(8): e77, 2019 08.

Article en En | MEDLINE | ID: mdl-29936440

Asunto(s)

Anticuerpos Antinucleares; Lupus Eritematoso Sistémico; Bioensayo; Humanos; Oxidación-Reducción

Palabras clave

disease activity; systemic lupus erythematosus; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Antinucleares / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google